Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 18
- Pharmaceutical
Standard Seed AI’s Platform Could Rewrite the Future of Cannabis Drug Discovery
At its core, Standard Seed AI’s technology has the power to scientifically validate the entourage effect, streamline drug discovery, and drastically reduce the time and cost of bringing cannabis-based medicines to market.
- Events
Cannabis Europa 2025 – Key Insights Day 2
Below, we’ve summarised the key insights from the vibrant and diverse discussions throughout Day 2 of Cannabis Europa 2025. If you’re keen to dive into the details, we’ll be exploring each session in more detail over the coming weeks.
- Hemp Industry
‘Seminal Moment’: Texas Hemp-Killing Bill Blocked as State Doubles Down on Medical Cannabis
Texas medical cannabis and hemp businesses both enjoyed some major, yet largely unexpected news over the weekend, not only ensuring the continued legality of hemp but significantly expanding the state’s medical cannabis programme.
- Press releases
Dalgety Signs Strategic Partnership with Curaleaf Laboratories
Dalgety, a UK-based EU-GMP certified medical cannabis cultivator, is pleased to announce a strategic partnership with Curaleaf Laboratories, a trusted name in cannabis medicine and pharmaceutical-quality cannabinoid innovation.
- Press releases
Glass Pharms Signs Supply Deal with Mamedica in ‘Milestone for UK Cultivation’
Under the collaboration, Glass Pharms will supply high-quality cannabis flower for use in Mamedica-branded, clinician-prescribed products, reinforcing the value of a fully domestic supply chain for CBPMs (Cannabis-Based Products for Medicinal Use).
- Medical
‘Access to Treatment Is Now a Right, Not a Privilege’: Ukraine Approves First Medical Cannabis Imports in Major Step Toward Access
Ukraine has issued its first medical cannabis import permit, marking a major milestone in its treatment rollout despite war-related regulatory challenges.
- Medical
Could Australia Be the Next Country to Impose Tariffs on Canadian Cannabis?
Australia’s medical cannabis market is thriving, with revenues expected to grow from around US$600m in 2024 to more than US$1.2bn by 2028, according to Prohibition Partners’ Global Cannabis Report: 5th Edition.
- Medical
US State Medical Cannabis Markets in ‘Dire Jeopardy’ as Critical Federal Protections Dropped by Trump
The Trump administration’s ‘One Big Beautiful Bill’, the federal government’s annual spending and tax omnibus legislation, has quietly dropped a key piece of legislation putting the country’s entire medical cannabis industry under threat.
- Companies
From Farm to Pharma: New Zealand’s Cannabis Powerhouses Are Coming to Europe
With Europe on their radar, a delegation of New Zealand companies is preparing to attend Cannabis Europa later this month. Business of Cannabis caught up with them ahead of the event to explore how they plan to connect with European counterparts, and where they see the most promising opportunities on the horizon.
- Data & Analysis
Germany’s Green Rush: Medical Cannabis Imports Continue Record Growth, As Political Pushback Grows in Tandem
German medical cannabis imports have continued their meteoric rise in the wake of the passage of its Cannabis Act (CanG), rising a further 15% on Q4, 2024 in the first quarter of 2025, totalling 37,223 kg.
- Your #1 Podcast on Cannabis News
Business of Cannabis: Podcast | The Broken Promise of UK Medical Cannabis – Releaf x Fieldfisher
The third in our series of guest episodes features a discussion between the CEO of Releaf, Tim Kirby, and Robert Jappie, a partner at Fieldfisher LLP specialising in regulatory law.
- Data & Analysis
The ‘Glaring Omission’ of the Endocannabinoid System From Mainstream Medical Knowledge, And its Real World Impact
Despite being one of the most important regulatory systems in human physiology, the endocannabinoid system (ECS) remains inexplicably absent from almost all mainstream medical education.
